Average Co-Inventor Count = 3.90
ph-index = 20
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of California (125 from 15,331 patents)
2. University of Vienna (61 from 71 patents)
3. Other (41 from 832,347 patents)
4. Emmanuelle Charpentier (20 from 20 patents)
5. Caribou Biosciences, Inc. (8 from 56 patents)
6. Yale University (4 from 1,317 patents)
7. Pfizer Corporation (1 from 4,448 patents)
8. National Technology & Engineering Solutions of Sandia, LLC (1 from 1,004 patents)
9. The J. David Gladstone Institute, a Testamentary Trust Established Under the Will of J. David Gladstone (1 from 2 patents)
137 patents:
1. 12365887 - CRISPR-Cas effector polypeptides and methods of use thereof
2. 12319963 - Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
3. 12312614 - CRISPR-Cas effector polypeptides and methods of use thereof
4. 12312616 - CRISPR-Cas effector polypeptides and methods of use thereof
5. 12286623 - Methods and kits for identifying cancer treatment targets
6. 12275966 - Genetically engineered cells
7. 12275964 - Variant type V CRISPR/Cas effector polypeptides and methods of use thereof
8. 12270027 - Methods and kits for identifying cancer treatment targets
9. 12264314 - CasZ compositions and methods of use
10. 12258575 - RNA-guided nucleic acid modifying enzymes and methods of use thereof
11. 12227753 - CasY compositions and methods of use
12. 12227547 - Modulators of CAS9 polypeptides and methods of use thereof
13. 12215377 - HIV or HCV detection with CRISPR-CAS13A
14. 12215343 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
15. 12180504 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription